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http://www.darujps.com/content/21/1/74RESEARCH ARTICLE Open AccessDiscovery of new angiotensin converting enzyme
(ACE) inhibitors from medicinal plants to treat
hypertension using an in vitro assay
Niusha Sharifi1, Effat Souri1, Seyed Ali Ziai2, Gholamreza Amin3 and Massoud Amanlou1,4*Abstract
Background and purpose of the study: Angiotensin converting enzyme (ACE) inhibitors plays a critical role in
treating hypertension. The purpose of the present investigation was to evaluate ACE inhibition activity of 50 Iranian
medicinal plants using an in vitro assay.
Methods: The ACE activity was evaluated by determining the hydrolysis rate of substrate, hippuryl-L-histidyl-L-leucine
(HHL), using reverse phase high performance liquid chromatography (RP-HPLC). Total phenolic content and antioxidant
activity were determined by Folin-Ciocalteu colorimetric method and DPPH radical scavenging assay respectively.
Results: Six extracts revealed > 50% ACE inhibition activity at 330 μg/ml concentration. They were Berberis integerrima
Bunge. (Berberidaceae) (88.2 ± 1.7%), Crataegus microphylla C. Koch (Rosaceae) (80.9 ± 1.3%), Nymphaea alba L.
(Nymphaeaceae) (66.3 ± 1.2%), Onopordon acanthium L. (Asteraceae) (80.2 ± 2.0%), Quercus infectoria G. Olivier. (Fagaceae)
(93.9 ± 2.5%) and Rubus sp. (Rosaceae) (51.3 ± 1.0%). Q. infectoria possessed the highest total phenolic content with
7410 ± 101 mg gallic acid/100 g dry plant. Antioxidant activity of Q. infectoria (IC50 value 1.7 ± 0.03 μg/ml) was more
than that of BHT (IC50 value of 10.3 ± 0.15 μg/ml) and Trolox (IC50 value of 3.2 ± 0.06 μg/ml) as the positive controls.
Conclusions: In this study, we introduced six medicinal plants with ACE inhibition activity. Despite the high ACE
inhibition and antioxidant activity of Q. infectoria, due to its tannin content (tannins interfere in ACE activity), another
plant, O. acanthium, which also had high ACE inhibition and antioxidant activity, but contained no tannin, could be
utilized in further studies for isolation of active compounds.
Keywords: Angiotensin converting enzyme, Screening, Medicinal plants, Total phenolic content, Antioxidant activityIntroduction
In 2000, 26.4% of the world’s population suffered hyper-
tension and it is predicted that this rate would increase
by 60% in 2025 [1]. Since the proportion of hyperten-
sive people will increase rapidly, new therapeutic ap-
proaches for management of hypertension are essential.
High blood pressure is a silent killer, causing several
serious diseases such as heart failure, kidney failure and
stroke. There are a number of choices for the treatment
of hypertension. Some treatments include diuretics,
β-blockers, calcium channel blockers and angiotensin II* Correspondence: amanlou@tums.ac.ir
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reproduction in any medium, provided the orreceptor blockers, the most common of which is angio-
tensin converting enzyme inhibitors.
Angiotensin converting enzyme, EC 3.4.15.1, is a
zinc metallopeptidase that converts the angiotensin I
(inactive decapeptide) to angiotensin II (a potent vaso-
constrictor), and bradykinin (a hypotensive peptide) to
inactive components [2]. High ACE activity leads to
increased concentration of angiotensin II and hyperten-
sion. Therefore, development of agents that inhibit the
conversion of angiotensin I to angiotensin II, and brady-
kinin to inactive components began as a therapeutic
strategy to treat hypertension. ACE inhibitors such as
captopril and lisinopril play key roles in treating hyper-
tension and maintaining the electrolyte balance [3].
They are commonly used as they are safe and well tole-
rated with few side effects.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cipitate proteins and interfere in the functions of many
macromolecules including ACE. Therefore, plants
with ≥ 50% ACE inhibition activity would be further
tested for the presence of tannins in order to eliminate
false positives [4].
Furthermore, reactive oxygen species (ROS) play a
significant role in cardiovascular diseases such as hyper-
tension and congestive heart failure. In hypertensive
patients, angiotensin II increases chronically and nico-
tinamide adenine dinucleotide phosphate (NADPH)
oxidase is activated, which causes a rise in ROS. As a re-
sult, it is more beneficial for an antihypertensive drug to
have antioxidant effect [5]. Phenolic compounds have
antioxidant activity and are effective agents to prevent
oxidative stress.
Natural products could be important sources of ACE
inhibitors such as captopril, a synthetic antihypertensive
drug, which is developed by changing and optimizing
the structure of the venom of the Brazilian viper. Active
substances derived from medicinal plants can also be a
source of new ACE inhibitors. Moreover, some plants
contain a great amount of phenolic compounds, so con-
sequently, they have antioxidant activity.
In this study, some medicinal plants that are used to
manage different diseases were screened to discover pos-
sible new ACE inhibition activity using an in vitro ACE
inhibition assay. Among the plants tested, the most ac-




Angiotensin converting enzyme (ACE) from rabbit lung,
hippuryl-L-histidyl-L-leucine (HHL), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer, hippuric acid
(HA) and captopril were purchased from Sigma-Aldrich
Co. (England). HCl, KH2PO4, methanol (HPLC grade),
2,2-diphenyl-1-picrylhydrazyl (DPPH), Folin-Ciocalteu
reagent, Na2CO3, gallic acid, butylated hydroxyl toluene
(BHT), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid (Trolox), FeCl3, NaCl, NaOH and dimethyl sulfoxide
(DMSO) were purchased from Merck Co. (Germany).
Ultrapure water was applied to prepare all of the aqueous
solutions.
Apparatus
Enzymatic incubation was performed in a thermomixer
eppendorf comfort (Germany). HPLC analysis was carried
out by a Knauer liquid chromatograph, with an ODS
Eurospher column (250 × 4.6 mm, 100–5; C18), protected
by a C18 precolumn (Perfectsil Target, ODS-3 (5 μm))
and a 20 μl injection loop. A smartline Photodiode Array
(PDA) detector 2850 (Knauer, Germany) was used todetect analytes, and a Chromgate software version 3.3,
was used for data processing. A Cecil UV/Vis spectro-
photometer (series 9000) was utilized to measure the
absorbances.
Plant materials
Some of the studied plants (41 plants) were purchased from
a local herbal store located in Tehran, Iran (June 2011).
Rubus sp. was collected from north of Iran, Mazandaran
province (June 2012), and 8 other plants were collec-
ted from Herburatum of Faculty of Pharmacy, Tehran
University of Medical Sciences (June 2011). All of the
mentioned plants were identified by Prof. G. Amin.
Voucher specimens of the collected plants were depo-
sited in the Herbarium of Tehran University of Medical
Sciences.
Preparation of crude extracts
Dried plant materials (1 g) were extracted with 20 ml
methanol:water (80:20, v/v) at room temperature for 24 h
and then over 2 h in an ultrasonic bath [6]. The extracts
were filtered and concentrated under reduced pressure,
using a rotary evaporator at room temperature and then
they were lyophilized.
ACE inhibition assay
In this study, the assay method is based on the hydro-
lysis of the substrate HHL by ACE, and measuring the
amount of HA using RP-HPLC [6-9]. HEPES buffer so-
lution used in this assay was prepared by dissolving
50 mM HEPES and 300 mM NaCl in 1000 ml water and
adjusting the solution to pH 8.3 by 1 M NaOH solution.
The substrate solution (9 mM) was prepared by dissol-
ving HHL (19.74 mg) in 5 ml of HEPES buffer. Herbal
extract (1 mg) was dissolved in 1 ml of solvent contai-
ning buffer/DMSO (90:10, v/v) to provide 330 μg/ml con-
centration (a comparable scale all over the world) [10].
First, ACE solution (25 μl) (80 mU/ml) was added to
25 μl of inhibitor solution (or solvent as negative control).
After 3 min preincubation at 37°C, 25 μl substrate solu-
tion was added and the mixture was incubated at 37°C for
30 min with shaking at 300 rpm in an Eppendorf thermo-
mixer. After 30 min, the reaction was stopped by addition
of 50 μl of 1 M HCl and then the reaction mixture was
subjected to RP-HPLC. The mobile phase was an isocra-
tic system consisting of a mixture of 10 mM KH2PO4
(adjusted to pH 3 with H3PO4) and methanol (50:50, v/v).
The flow rate was 1 ml/min and the injection volume was
20 μl. Analytes were detected by a PDA detector at the
wavelength of 228 nm.
ACE inhibition measurement
ACE inhibition calculation was based on the ratio of the
area under curve (AUC) of HA peak in an inhibitor
Table 1 Angiotensin converting enzyme (ACE) inhibition activity of the 50 studied plants*




Collection site Medicinal use Voucher No Inhibition%
Abrus precatorius L. (Leguminosae) Cheshm- e Khorus Seed LHSa Tonic, astringent PMP - 725b −13.1
Alcea sp. (Malvaceae) Khatmi Flower LHS Diuretic, demulcent,
disinfectant
PMP - 503 −27.3
Allium cepa L. (Alliaceae) Tokhm- e pyaz Seed LHS Anti-typhoid fever PMP - 726 21.2
Amaranthus lividus L.
(Amaranthaceae)
Tokhm- e tajkhorus Seed LHS Treatment of anemia PMP - 723 −13.9
Amomum subulatum Roxb.
(Zingiberaceae)
Hel- e bad Fruit LHS Stomach tonic, carminative PMP - 634 −11.6
Arnebia euchroma (Royle)
I. M. Johnst. (Boraginaceae)
Havachobe Root LHS Disinfectant PMP - 211 −8.1





Zereshk- e abi Fruit LHS Tonic, laxative, refrigerant,
antiseptic
PMP - 619 88.2 ± 1.7c
Biebersteinia sp. (Geraniaceae) Chelledaghi Root LHS Anti-rheumatic PMP - 215 22.7
Cerasus avium (L.)
Moench (Rosaceae)
Dom- e gilas Tail LHS Cardiac tonic, diuretic PMP - 309 28.4
Chelidonium majus L. (Papaveraceae) Mamiran Root LHS Anti-diarrhea,
anti-liver disease
PMP - 314 0.0
Cichorium intybus L. (Compositae) Kasni Root LHS Diuretic, analgesic,
anti-fever
PMP - 213 13.2
Colchicum sp. (Colchicaceae) Suranjan Rhizome LHS Anti-pain in gout PMP - 214 19.6
Commiphora sp. (Burseraceae) Moql Resin LHS Anti-rheumatic PMP - 812 20.8
Cordia myxa L. (Boraginaceae) Sepestan Fruit LHS Mucilage, anti-chest
complaints
PMP - 730 −15.9
Crataegus microphylla C.
Koch (Rosaceae)
Sorkhevalik Leaf LHS Cardiac tonic, diuretic,
hypotensive
PMP - 306 80.9 ± 1.3
Cucurbita pepo L. (Cucurbitaceae) Tokhm- e kadu Seed LHS Anti-fever, anti-gastrointestinal
parasites
PMP - 729 −31.5
Cynodon dactylon (L.)
Pers. (Gramineae)
Margh Rhizome LHS Diuretic PMP - 312 9.6
Datura stramonium L.
(Solanaceae)
Tature Leaf LHS Anti-asthma PMP - 728 22.3
Dorema ammoniacum Don.
(Umbelliferae)
Vasha Resin LHS Anti-gastrointestinal parasites PMP - 815 14.2







Echinops sp. (Compositae) Shekartighal Resin LHS Demulcent, anti-cough,
anti-fever
PMP - 817 2.1
Elettaria cardamomum (L.) Maton
(Zingiberaceae)
Hel- e sabz Fruit LHS Spice, stomach tonic,
carminative
PMP - 630 −25.7
Entada rheedii Spreng. (Leguminosae) Qorc- e kamar Seed LHS Ointment for backache PMP - 724 17.3
Eugenia caryophyllata Thunb.
(Myrtaceae)
Mikhak Flower LHS Anti-dental pain, disinfectant PMP - 504 −34.4
Ferula asssa-foetida L.
(Umbelliferae)
Anqoze Resin LHS Anti-gastrointestinal parasites PMP - 816 −40.3
Ferula gumosa Boiss.
(Umbelliferae)
Barije Resin LHS Stomach tonic PMP - 814 −36.7
Foeniculum vulgare Mill.
(Umbelliferae)
Razyane Seed LHS Tonic, diuretic, carminative PMP - 632 −9.2
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Table 1 Angiotensin converting enzyme (ACE) inhibition activity of the 50 studied plants* (Continued)
Heracleum persicum Desf.
(Umbelliferae)
Golpar Fruit LHS Spice, disinfectant,
carminative
PMP - 631 4.7
Iris sp. (Iridaceae) Rishe- e irisa Root LHS Diuretic, cathartic PMP - 212 0.0
Lepidium sativum L. (Cruciferae) Tokhm- e shahi Seed LHS Tonic PMP - 722 −2.2
Malva sylvestris L. (Malvaceae) Panirak Flower H Mucilage, anti-cough 84450 21.7
Matricaria inodora L. (Asteraceae) Babuneh Flower H Carminative, febrifuge 83452 −7.5
Nymphaea alba L. (Nymphaeaceae) Gol- e nilufar Flower LHS Diuretic, sedative PMP - 501 66.3 ± 1.2
Onopordon acanthium L.
(Asteraceae)
Khajebashi Seed LHS Hypotensive, diuretic,
cardiac tonic
PMP - 714 80.2 ± 2.0
Passiflora caerulea L.
(Passifloraceae)
Gol- e saati Flower H Spinal depressant,
respiratory stimulant
84568 −33.2
Plantago ovata Phil. (Plantaginaceae) Esfarze Seed LHS Laxative, anti-hemorrhoids PMP - 731 −24.2
Quercus infectoria G.Olivier.
(Fagaceae)
Jaft Bark LHS Anti-diarrhea, astringent,
antibacterial
PMP - 621 93.9 ± 2.5
Rosmarinus officinalis L. (Lamiaceae) Rosaemary Leaf H Spice, herb, carminative,
GI irritant
83636 0.0
Rubus sp. (Rosaceae) Tameshk Leaf Na Hypotensive, anti-diarrhea PMP - 404 51.3 ± 1.0
Salvia macrosiphon Boiss. (Labiatae) Tokhm- e marv Seed LHS Demulcent, anti-cough PMP - 721 −11.7
Saponaria officinalis L.
(Caryophyllaceae)
Gol- e sabooni Flower H Expectorant, laxative 84680 −33.6
Satureja hortensis L. (Labiatae) Tokhm- e marze Seed LHS Anti-muscle pain,
anti-rheumatic
PMP - 732 34.4
Tanacetum Balsamita L.
(Compositae)
Shahesparam Leaf LHS Stomach tonic, anti-nausea PMP - 405 −15.2
Terminalia chebula Retz.
(Combretaceae)
Halil- e zard Fruit LHS Stomach tonic, anti-diarrhea PMP - 633 17.9
Terminalia chebula Retz.
(Combretaceae)
Halil- e siah Fruit LHS Cathartic PMP - 629 15.2
Teucrium polium L. (Labiatae) Maryam nokhodi Aerial
part
LHS Cold treatment, anti-fever PMP - 313 2.1
Vitex agnus-castus L. (Verbenaceae) Panj anghosht Flower H Anti-androgen, carminative 84802 31.4
Zataria multiflora Boiss. (Labiatae) Avishan- e shirazi Leaf LHS Cold treatment, carminative PMP - 310 24.8
Zea mays L. (Gramineae) Kakol- e zhorrat Herb LHS Diuretic, urethra antiseptic PMP - 311 −35.7
*All medicinal plants were collected in June 2011 except Rubus sp. which is collected in June 2012.
aLHS, Local Herbal Store; H, Herburatum of Tehran University of Medical Sciences (http://pharmacy.tums.ac.ir); N, North of Iran (Mazandaran province).
bPMP, Popular Medicinal Plant.
cValues are means ± SD of three measurements for 6 active plants.
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pressed by equation 1:
ACE inhibition %ð Þ ¼ 1‐ AUC inhibitor=AUC controlð Þ½ 
 100
AUC inhibitor : AUC of the HA peak with inhibitor
AUC control : AUC of the HA peak of control sample
without inhibitor
ð1Þ
Gelatin salt block test (eliminating false positive results)
In order to detect tannins, extracts with ≥ 50% ACE inhi-
bition activity were tested under gelatin salt block test.Active extracts (200 mg) were dissolved in 4 ml water
(50°C) and allowed to reach room temperature. To re-
move non-tannin compounds, a few drops of an aqueous
10% NaCl solution was added to the extracts. After filtra-
tion, the filtrate (1 ml) was added to four test tubes. Tube
1 contained 4–5 drops of 1% gelatin solution. Tube 2 con-
tained 4–5 drops of 1% gelatin + 10% NaCl solution. Tube
3 contained 3–4 drops of 10% ferric chloride solution, and
tube 4, was a control sample containing no reagent. Tube
1 and 2 were observed for the formation of precipitate,
while tube 3 was observed for color [4].
The presence of greenish-blue or greenish-black color
following the addition of ferric chloride indicates the
presence of condensed tannins, and bluish-black color
Table 3 Results of gelatin salt block test in order to
detect tannin in extracts
Scientific
name




B. integerrima NPa NP Green/black
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(assuming that precipitation is the result of gelatin salt
block test). The presence of greenish-black or bluish-black
color after the addition of ferric chloride with negative
gelatin salt block test indicated no tannins in that extract.C. microphylla NP NP Green/black
N. alba NP NP Blue/black
O. acanthium NP NP Green/black
Q. infectoria Pb P Green/black
Rubus sp. NP NP Blue/black
aNP, no precipitate; bP, precipitate.Total phenolic content (TP)
Folin-Ciocalteu colorimetric method [11] was used to
determine the total phenolic content of extracts. First,
Folin-Ciocalteu reagent (0.5 ml) was added to 0.5 ml of
methanol extract solution (100 mg/ml). Then Na2CO3
(0.5 ml) (100 mg/ml) was added to the mixture. The ab-
sorbance was measured at 760 nm, after 60 min incu-
bation at room temperature. Calibration curve of gallic
acid in different concentrations (1, 10, 100, 500 and
1000 μg/ml) was prepared using the same method. Total
phenolic content of each extract was calculated from
calibration curve of gallic acid and reported as mg of
gallic acid equivalent in 100 g dry of plant [12].Table 4 Total phenolic content and antioxidant activity of
active extracts
Scientific name Tpa (mg gallic acid/100 g dry plant) IC50
b(μg/ml)DPPH radical scavenging activity
The DPPH radical scavenging activity assay is a method
for determining the ability of extracts to trap free radicals
[13]. First, DPPH methanol solution (2.0 ml) (0.16 mM)
was added to 2.0 ml of extract methanol solutions in dif-
ferent concentrations. Next the same sample was prepared
with 2.0 ml methanol replacing extract methanol solution
as control. After that the mixtures were vortexed for
1 min and left at room temperature for 30 min. Later the
absorbance (Abs) were read at 517 nm. For calculating
radical scavenging activity (RSA), the equation 2 was used:
RSA %ð Þ ¼ 1‐ Abs extract=Abs controlð Þ½   100
Abs extract : Absorbance of the extract sample
Abs control : Absorbance of the control sample
ð2Þ
Radical scavenging activity of extracts was compared
with those of BHT and Trolox as the positive controls.Table 2 The active medicinal plants with more than 50%
ACE inhibition activity at 330 μg/ml concentration
Scientific name Percent of inhibitiona
B. integerrima 88.2 ± 1.7
C. microphylla 80.9 ± 1.3
N. alba 66.3 ± 1.2
O. acanthium 80.2 ± 2.0
Q. infectoria 93.9 ± 2.5
Rubus sp. 51.3 ± 1.0
aValues are means ± SD of three measurements.Establishing the sensitivity of the ACE assay system
The half maximal inhibitory concentration (IC50) value of
captopril was determined from concentration - response
curve by nonlinear regression, using GraphPad Prism soft-
ware version 5, and it was compared with the value in the
literature. The IC50 value for captopril determined in this
study was 25 ± 2.6 nM, which was close to the value
(23 nM) in the literature [14].
Results
ACE inhibition activity
Table 1 illustrates scientific names, plant families, common
names in Persian, parts used, collection sites, collection
times, medicinal uses, voucher numbers and ACE inhi-
bition activities of herbal extracts. Of a total of fifty herbal
extracts, six extracts have shown inhibition activity more
than 50% at 330 μg/ml concentration (Table 2). They were
B. integerrima (88.2 ± 1.7%), C. microphylla (80.9 ± 1.3%),
N. alba (66.3 ± 1.2%), O. acanthium (80.2 ± 2.0%), Q. infec-
toria (93.9 ± 2.5%) and Rubus sp. (51.3 ± 1.0%).
Tannin test
Out of six active extracts investigated in this study, only
the extract of Q. infectoria produced a positive gelatin
salt block test (Table 3). The presence of greenish-blackB. integerrima 2250 ± 37 15.3 ± 0.20
C. microphylla 2000 ± 29 13.1 ± 0.20
N. alba 3860 ± 36 10.2 ± 0.15
O. acanthium 2740 ± 26 7.0 ± 0.09
Q. infectoria 7410 ± 101 1.7 ± 0.03
Rubus sp. 3870 ± 26 11.3 ± 0.22
BHT _ 10.3 ± 0.15
Trolox _ 3.2 ± 0.06
aTp, Total phenolic content.
bIC50, radical scavenging activity in DPPH assay.
Values are means ± SD of three independent measurements.
Figure 1 The picture of active medicinal plants with more than 50% angiotensin converting enzyme inhibitory activity. A) B. integerrima
B) C. microphylla C) N. alba D) O. acanthium E) Q. infectoria F) Rubus sp [26-31].
Sharifi et al. DARU Journal of Pharmaceutical Sciences 2013, 21:74 Page 6 of 8
http://www.darujps.com/content/21/1/74or bluish-black color after the addition of ferric chloride
with negative gelatin salt block test indicated no tannins
in other extracts.
Total phenolic content and radical scavenging activity
Oxidative stress plays a critical role in cardiovascular
disease [15]. Phenolic compounds are responsible for
antioxidant activity due to their ability for scavenging free
radicals. Therefore, total phenolic content and radical
scavenging activities of these six medicinal plants were de-
termined (Table 4). Most of these six extracts had a large
phenolic content. In DPPH radical scavenging assay, IC50
values of six plant extracts were determined and com-
pared with those of BHT and Trolox as the positive con-
trols (Table 4). Q. infectoria possessed more antioxidant
activity (IC50 value of 1.7 ± 0.03 μg/ml), compared to thatFigure 2 The correlation between total phenolic content and DPPH raof BHT (IC50 value of 10.3 ± 0.15 μg/ml) and Trolox (IC50
value of 3.2 ± 0.06 μg/ml).
Discussion
Hypertension, a worldwide illness, is a major factor in
cardiovascular diseases that affects a large population of
adults. One of the most effective medications for the
treatment of hypertension is angiotensin converting en-
zyme inhibitors. Meanwhile, medicinal plants have been
used for treating illnesses. Therefore, they can be im-
portant resources to develop new drug candidates [16].
As illustrated in Table 1 six extracts showed inhibition
activity more than 50%, nineteen extracts showed inhi-
bition activity less than 50% and 25 of them showed no
inhibition activity at 330 μg/ml concentration. Among
these active medicinal plants, three ones (C. microphylla,dical scavenging activity for six plant extracts.
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ment of hypertension in traditional medicine and this re-
search revealed that the mechanism of action of the
three mentioned plants in treatment of hypertension
could be done through ACE inhibition.
In addition, Antihypertensive activity is reported in
traditional medicine for similar species of the above men-
tioned plants including Crataegus oxyacantha [17], Ono-
pordon leptolepis and Onopordon carmanicum [18].
Flavonoids [19], flavanols [20], flavonols [21], antho-
cyanins [22], isoflavones [23], flavones [24] and other
phenolic compounds have proved to be effective in de-
creasing the ACE activity. Therefore, the above mentioned
secondary metabolites could be responsible for ACE in-
hibition activity in these 6 active extracts.
On the other hand, such ACE inhibitors with antioxi-
dant activity might be useful to treat other diseases which
are caused as a result of a rise in ROS production [25].
The highest ACE inhibition activity (93.9 ± 2.5%) was
observed at 330 μg/ml concentration in Q. infectoria. It is
clear that tannins are phenolic natural products that inter-
fere in enzymatic activity. Consequently, we checked for
its presence in our active extracts (extracts with ≥ 50%
ACE inhibition activity). Unfortunately, greenish-black
color after the addition of ferric chloride with positive
gelatin salt block test indicated the presence of condensed
tannins in Q. infectoria extract. Therefore, in spite of high
ACE inhibition and antioxidant activity, it is not the
plant of choice for further studies to isolate the active
compounds.
Among other active medicinal plants, three ones inclu-
ding B. integerrima, C. microphylla and O. acanthium
possessed > 80% ACE inhibition activity. Out of the three
mentioned plants, O. acanthium possessed more antioxi-
dant activity (IC50 value of 7 ± 0.09 μg/ml), compared to
that of B. integerrima (IC50 value of 15.3 ± 0.2 μg/ml) and
C. microphylla (IC50 value of 13.1 ± 0.2 μg/ml). Therefore,
because of high ACE inhibition and antioxidant activity,
O. acanthium is a valuable medicinal plant for isolation of
active compounds.
Furthermore, N. alba and Rubus sp. are moderate ACE
inhibitors and after the above three mentioned plants, are
valuable plants for isolation of active compounds in fur-
ther studies.
Conclusions
Medicinal plants presented in Table 2 are potential
sources for developing new ACE inhibitors (Figure 1)
[26-31]. There was a linear relationship between total
phenolic content and radical scavenging activity with
equation formula, y = 83.53 × - 823.4; R2 = 0.714 (Figure 2).
As shown in Tables 2, 3 and 4, in spite of possessing the
highest ACE inhibition and antioxidant activity, Q. in-
fectoria had tannin content. On the other hand, O.acanthium, which also had high ACE inhibition and anti-
oxidant activity containing no tannin, and could be used
in further studies for isolation of active compounds.
Competing interests
The authors have no conflict of interests to declare.
Authors’ contributions
NS: Performed the experimental work including plant extraction, biological
tests, data interpretation, and manuscript preparation. ES: Was responsible
for HPLC analysis. SAZ: Was involved in designing the experiments. GHA:
Identified all plants. MA: Was responsible for the study registration, financial
and administrative support, and also gave final approval of the version to be
published. All authors read and approved the final manuscript.
Acknowledgment
The financial support of the Research Council of the Tehran University of
Medical Sciences is gratefully acknowledged.
Author details
1Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University
of Medical Sciences, Tehran, Iran. 2Department of Pharmacology, Faculty of
Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of
Medical Sciences, Tehran, Iran. 4Medicinal Plants Research Center, Faculty of
Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Received: 17 June 2013 Accepted: 28 August 2013
Published: 20 December 2013
References
1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global
burden of hypertension: analysis of worldwide data. Lancet 2005,
365:217–223.
2. Skeggs SLT, Kahn JR, Shumway NP: The preparation and function of the
angiotensin I converting enzyme. J Exp Med 1956, 103:295–299.
3. Carretero OA, Oparil S: Essential hypertension.Part I: definition and
etiology. Circulation 2000, 101:329–335.
4. Duncan AC, Jager AK, Staden JV: Screening of Zulu medicinal plants for
angiotensin converting enzyme (ACE) inhibitors. J Ethnopharmacol 1999,
68:63–70.
5. Griendling KK, Candace A, Minieri CA, Ollerenshaw JD, Alexander RW:
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured
vascular smooth muscle cells. Circ Res 1994, 74:1141–1148.
6. Kouchmeshky A, Jameie SB, Amin G, Ziai SA: Investigation of angiotensin-
converting enzyme inhibitory effects of medicinal plants used in traditional
Persian medicine for treatment of hypertension, screening study.
Thrita Stud J Med Sci 2012, 1:13–23.
7. Horiuchi M, Fujimura K, Terashima T, Iso T: Method for determination of
angiotensin converting enzyme activity in blood and tissue by high
performance liquid chromatography. J Chromatogr 1982, 233:123–130.
8. Mehanna AS, Dowling M: Liquid chromatographic determination of
hippuric acid for the evaluation of ethacrynic acid as angiotensin
converting enzyme inhibitor. J Pharm Biomed Anal 1999, 19:967–973.
9. Schnaith E, Beyrau R, Buckner B, Klein RM, Rick W: Optimized
determination of angiotensin I converting enzyme activity with hippuril-
L-histidyl-L-leucine as substrate. Clin Chim Acta 1994, 227:145–158.
10. Tundis R, Loizzo MR, Statti GA, Deguin B, Amissah R, Houghton PJ, et al:
Chemical composition of and inhibition of angiotensin-converting
enzyme by Senecio samnitum huet. Pharm Biol 2005, 43:605–608.
11. Singleton VL, Orthofer R, Lamuela-Raventos RM: Analysis of total phenols and
other oxidation substrates and antioxidants by means of Folin-Ciocalteu
reagent. Methods Enzymol 1999, 299:152–178.
12. Lachman J, Hamouz K, Orsak M, Pivec V: Potato tubers as a significant
source of antioxidant human nutrition. Rostl Vyr 2000, 46:231–236.
13. Yen GC, Chen HY: Antioxidant activity of various tea extracts in relation
to their antimutagenicity. J Agric Food Chem 1995, 43:27–37.
14. Ondetti MA: Structural relationships of angiotensin converting enzyme
inhibitors to pharmacologic activity. Circulation 1988, 77:74–78.
15. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in
cardiovascular diseases. J Hypertens 2000, 18:655–673.
Sharifi et al. DARU Journal of Pharmaceutical Sciences 2013, 21:74 Page 8 of 8
http://www.darujps.com/content/21/1/7416. Lipp FJ: The efficacy, history, and politics of medicinal plants. Altern Ther
Health Med 1996, 2:36–41.
17. Lacaille-Dubois MA, Franck U, Wagner H: Search for potential Angiotensin
Converting Enzyme (ACE)-inhibitors from plants. Phytomedicine 2001,
8:47–52.
18. Esmaeili A, Saremnia B: Preparation of extract-loaded nanocapsules from
Onopordon leptolepis DC. Ind Crop Prod 2012, 37:259–263.
19. Ojeda D, Jiménez-Ferrer E, Zamilpa A, Herrera-Arellano A, Tortoriello J,
Alvarez L: Inhibition of angiotensin converting enzyme (ACE) activity by
the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from
Hibiscus sabdariffa. J Ethnopharmacol 2010, 127:7–10.
20. Ottaviani JI, Actis-Goretta L, Villordo JJ, Fraga CG: Procyanidin structure
defines the extent and specificity of angiotensin I converting enzyme
inhibition. Biochimie 2006, 88:359–365.
21. Oh H, Kang DG, Kwon JW, Kwon TO, Lee SY, Lee DB, et al: Isolation of
angiotensin converting enzyme (ACE) inhibitory flavonoids from Sedum
sarmentosum. Biol Pharm Bull 2004, 27:2035–2037.
22. Kwon EK, Lee DY, Lee H, Kim DO, Baek NI, Kim YE, et al: Flavonoids from the
buds of Rosa damascena inhibit the activity of 3-hydroxy-3-methylglutaryl-
coenzyme a reductase and angiotensin I-converting enzyme. J Agric Food
Chem 2010, 58:882–886.
23. Montenegro MF, Pessa LR, Tanus-Santos JE: Isoflavone genistein inhibits
the angiotensin converting enzyme and alters the vascular responses to
angiotensin I and bradykinin. Eur J Pharmacol 2009, 607:173–177.
24. Loizzo MR, Said A, Tundis R, Rashed K, Statti GA, Hufner A, et al: Inhibition
of angiotensin converting enzyme (ACE) by flavonoids isolated from
Ailanthus excels (Roxb) (Simaroubaceae). Phytother Res 2007, 21:32–36.
25. Hasani-Ranjbar S, Larijani B, Abdollahi M: A systematic review of the
potential herbal sources of future drugs effective in oxidant-related
diseases. Inflamm Allergy Drug Targets 2009, 8:2–10.
26. Berberis integerrima. http://www.plantsystematics.org/imgs/kcn2/r/
Berberidaceae_Berberis_sp_1445.html. webcite (accessed September 6, 2013).
27. Crategus microphylla. http://www.plantarium.ru/page/image/id/155248.html.
webcite (accessed September 6, 2013).
28. Wikipedia contributors: Nymphaea alba. Wikipedia, The Free Encyclopedia.
http://en.wikipedia.org/wiki/Nymphaea_alba. webcite (accessed September
6, 2013).
29. Wikipedia contributors: Ononpordum acanthium. Wikipedia, The Free
Encyclopedia. http://en.wikipedia.org/wiki/Onopordum_acanthium. webcite
(accessed September 6, 2013).
30. Quercus infectoria. http://www.biolib.cz/en/taxonimage/id77341 webcite
(Pavel Bursik). (accessed September 6, 2013).
31. Wikipedia contributors: Rubus sp.. Wikipedia, The Free Encyclopedia.
http://en.wikipedia.org/wiki/Rubus webcite (accessed September 6, 2013).
doi:10.1186/2008-2231-21-74
Cite this article as: Sharifi et al.: Discovery of new angiotensin
converting enzyme (ACE) inhibitors from medicinal plants to treat
hypertension using an in vitro assay. DARU Journal of Pharmaceutical
Sciences 2013 21:74.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
